Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation

Luisa M. Rodríguez, Richard J. Knight, Rubina A. Heptulla

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Simultaneous pancreas-kidney (SPK) transplantation is an important replacement therapy for individuals with diabetes and end-stage renal disease. Kidney-alone (KA) transplantation is associated with a high incidence of post-transplant diabetes. Methods: This was a cross-sectional study. We studied 48-h glucose concentrations in eight subjects with type 1 diabetes mellitus after SPK transplantation, six subjects post-KA transplantation, and nine healthy controls using the CGMS® (Medtronic Minimed, Northridge, CA) continuous glucose monitoring system. Results: The 48-h mean glucose concentration was 101±7mg/dL in the SPK subjects, 105±12mg/dL in the KA subjects, and 99±7mg/dL in the healthy controls. The glycemic excursions were higher in the KA group compared to the SPK cohort and healthy controls (P<0.0001). No differences in the incidence of hypoglycemia were detected among the three groups. Significant postprandial hyperglycemia was uncovered in four of the six KA subjects. Conclusions: SPK transplantation is very effective at normalizing glycemic excursions. Unsuspected hyperglycemia was identified in the KA group. The CGMS was a useful ambulatory tool to study glucose profiles in the post-transplant period and may help uncover hyperglycemia undetected by routine laboratory testing.

Original languageEnglish (US)
Pages (from-to)347-351
Number of pages5
JournalDiabetes Technology and Therapeutics
Volume12
Issue number5
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Kidney Transplantation
Pancreas
Kidney
Glucose
Pancreas Transplantation
Hyperglycemia
Transplants
Incidence
Type 1 Diabetes Mellitus
Hypoglycemia
Chronic Kidney Failure
Cross-Sectional Studies

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. / Rodríguez, Luisa M.; Knight, Richard J.; Heptulla, Rubina A.

In: Diabetes Technology and Therapeutics, Vol. 12, No. 5, 01.05.2010, p. 347-351.

Research output: Contribution to journalArticle

Rodríguez, Luisa M. ; Knight, Richard J. ; Heptulla, Rubina A. / Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. In: Diabetes Technology and Therapeutics. 2010 ; Vol. 12, No. 5. pp. 347-351.
@article{d1d51be0c38c4e96bded5c886e7b2637,
title = "Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation",
abstract = "Background: Simultaneous pancreas-kidney (SPK) transplantation is an important replacement therapy for individuals with diabetes and end-stage renal disease. Kidney-alone (KA) transplantation is associated with a high incidence of post-transplant diabetes. Methods: This was a cross-sectional study. We studied 48-h glucose concentrations in eight subjects with type 1 diabetes mellitus after SPK transplantation, six subjects post-KA transplantation, and nine healthy controls using the CGMS{\circledR} (Medtronic Minimed, Northridge, CA) continuous glucose monitoring system. Results: The 48-h mean glucose concentration was 101±7mg/dL in the SPK subjects, 105±12mg/dL in the KA subjects, and 99±7mg/dL in the healthy controls. The glycemic excursions were higher in the KA group compared to the SPK cohort and healthy controls (P<0.0001). No differences in the incidence of hypoglycemia were detected among the three groups. Significant postprandial hyperglycemia was uncovered in four of the six KA subjects. Conclusions: SPK transplantation is very effective at normalizing glycemic excursions. Unsuspected hyperglycemia was identified in the KA group. The CGMS was a useful ambulatory tool to study glucose profiles in the post-transplant period and may help uncover hyperglycemia undetected by routine laboratory testing.",
author = "Rodr{\'i}guez, {Luisa M.} and Knight, {Richard J.} and Heptulla, {Rubina A.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1089/dia.2009.0157",
language = "English (US)",
volume = "12",
pages = "347--351",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation

AU - Rodríguez, Luisa M.

AU - Knight, Richard J.

AU - Heptulla, Rubina A.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Background: Simultaneous pancreas-kidney (SPK) transplantation is an important replacement therapy for individuals with diabetes and end-stage renal disease. Kidney-alone (KA) transplantation is associated with a high incidence of post-transplant diabetes. Methods: This was a cross-sectional study. We studied 48-h glucose concentrations in eight subjects with type 1 diabetes mellitus after SPK transplantation, six subjects post-KA transplantation, and nine healthy controls using the CGMS® (Medtronic Minimed, Northridge, CA) continuous glucose monitoring system. Results: The 48-h mean glucose concentration was 101±7mg/dL in the SPK subjects, 105±12mg/dL in the KA subjects, and 99±7mg/dL in the healthy controls. The glycemic excursions were higher in the KA group compared to the SPK cohort and healthy controls (P<0.0001). No differences in the incidence of hypoglycemia were detected among the three groups. Significant postprandial hyperglycemia was uncovered in four of the six KA subjects. Conclusions: SPK transplantation is very effective at normalizing glycemic excursions. Unsuspected hyperglycemia was identified in the KA group. The CGMS was a useful ambulatory tool to study glucose profiles in the post-transplant period and may help uncover hyperglycemia undetected by routine laboratory testing.

AB - Background: Simultaneous pancreas-kidney (SPK) transplantation is an important replacement therapy for individuals with diabetes and end-stage renal disease. Kidney-alone (KA) transplantation is associated with a high incidence of post-transplant diabetes. Methods: This was a cross-sectional study. We studied 48-h glucose concentrations in eight subjects with type 1 diabetes mellitus after SPK transplantation, six subjects post-KA transplantation, and nine healthy controls using the CGMS® (Medtronic Minimed, Northridge, CA) continuous glucose monitoring system. Results: The 48-h mean glucose concentration was 101±7mg/dL in the SPK subjects, 105±12mg/dL in the KA subjects, and 99±7mg/dL in the healthy controls. The glycemic excursions were higher in the KA group compared to the SPK cohort and healthy controls (P<0.0001). No differences in the incidence of hypoglycemia were detected among the three groups. Significant postprandial hyperglycemia was uncovered in four of the six KA subjects. Conclusions: SPK transplantation is very effective at normalizing glycemic excursions. Unsuspected hyperglycemia was identified in the KA group. The CGMS was a useful ambulatory tool to study glucose profiles in the post-transplant period and may help uncover hyperglycemia undetected by routine laboratory testing.

UR - http://www.scopus.com/inward/record.url?scp=77951118509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951118509&partnerID=8YFLogxK

U2 - 10.1089/dia.2009.0157

DO - 10.1089/dia.2009.0157

M3 - Article

C2 - 20388044

AN - SCOPUS:77951118509

VL - 12

SP - 347

EP - 351

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 5

ER -